Details for Patent: 11,103,497
✉ Email this page to a colleague
Which drugs does patent 11,103,497 protect, and when does it expire?
Patent 11,103,497 protects BOSULIF and is included in two NDAs.
Protection for BOSULIF has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-eight patent family members in twenty-two countries.
Summary for Patent: 11,103,497
| Title: | Treatment of imatinib resistant leukemia |
| Abstract: | The present invention provides 4-anilino-3-quinolinecarbonitriles compounds useful for treating a subject having an BcrAbl positive leukemia that is resistant to imatinib. |
| Inventor(s): | Hewes; Becker (Middlesex, MA) |
| Assignee: | Wyeth LLC (New York, NY) |
| Application Number: | 12/129,935 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 11,103,497
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pf Prism Cv | BOSULIF | bosutinib monohydrate | CAPSULE;ORAL | 217729-001 | Sep 26, 2023 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Pf Prism Cv | BOSULIF | bosutinib monohydrate | CAPSULE;ORAL | 217729-002 | Sep 26, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Pf Prism Cv | BOSULIF | bosutinib monohydrate | TABLET;ORAL | 203341-001 | Sep 4, 2012 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Pf Prism Cv | BOSULIF | bosutinib monohydrate | TABLET;ORAL | 203341-003 | Oct 27, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Pf Prism Cv | BOSULIF | bosutinib monohydrate | TABLET;ORAL | 203341-002 | Sep 4, 2012 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,103,497
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2008260070 | ⤷ Try a Trial | |||
| Brazil | PI0812355 | ⤷ Try a Trial | |||
| Canada | 2688467 | ⤷ Try a Trial | |||
| Canada | 2868899 | ⤷ Try a Trial | |||
| Canada | 2964162 | ⤷ Try a Trial | |||
| Chile | 2008001577 | ⤷ Try a Trial | |||
| China | 101686973 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
